Copyright Reports & Markets. All rights reserved.

Global Perphenazine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Perphenazine Market Overview

      • 1.1 Product Overview and Scope of Perphenazine
      • 1.2 Perphenazine Segment by Type
        • 1.2.1 Global Perphenazine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral Forms
        • 1.2.3 Injectable Solution
      • 1.3 Perphenazine Segment by Application
        • 1.3.1 Perphenazine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Psychosis
        • 1.3.3 Antiemetic
      • 1.3 Global Perphenazine Market by Region
        • 1.3.1 Global Perphenazine Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Perphenazine Market Size
        • 1.4.1 Global Perphenazine Revenue (2014-2025)
        • 1.4.2 Global Perphenazine Production (2014-2025)

      2 Global Perphenazine Market Competition by Manufacturers

      • 2.1 Global Perphenazine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Perphenazine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Perphenazine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Perphenazine Production Sites, Area Served, Product Types
      • 2.5 Perphenazine Market Competitive Situation and Trends
        • 2.5.1 Perphenazine Market Concentration Rate
        • 2.5.2 Perphenazine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Perphenazine Production Market Share by Regions

      • 3.1 Global Perphenazine Production Market Share by Regions
      • 3.2 Global Perphenazine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Perphenazine Production
        • 3.4.1 North America Perphenazine Production Growth Rate (2014-2019)
        • 3.4.2 North America Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Perphenazine Production
        • 3.5.1 Europe Perphenazine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Perphenazine Production (2014-2019)
        • 3.6.1 China Perphenazine Production Growth Rate (2014-2019)
        • 3.6.2 China Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Perphenazine Production (2014-2019)
        • 3.7.1 Japan Perphenazine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Perphenazine Consumption by Regions

      • 4.1 Global Perphenazine Consumption by Regions
      • 4.2 North America Perphenazine Consumption (2014-2019)
      • 4.3 Europe Perphenazine Consumption (2014-2019)
      • 4.4 China Perphenazine Consumption (2014-2019)
      • 4.5 Japan Perphenazine Consumption (2014-2019)

      5 Global Perphenazine Production, Revenue, Price Trend by Type

      • 5.1 Global Perphenazine Production Market Share by Type (2014-2019)
      • 5.2 Global Perphenazine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Perphenazine Price by Type (2014-2019)
      • 5.4 Global Perphenazine Production Growth by Type (2014-2019)

      6 Global Perphenazine Market Analysis by Applications

      • 6.1 Global Perphenazine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Perphenazine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Perphenazine Business

      • 7.1 Teva
        • 7.1.1 Teva Perphenazine Production Sites and Area Served
        • 7.1.2 Perphenazine Product Introduction, Application and Specification
        • 7.1.3 Teva Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Sandoz
        • 7.2.1 Sandoz Perphenazine Production Sites and Area Served
        • 7.2.2 Perphenazine Product Introduction, Application and Specification
        • 7.2.3 Sandoz Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Endo
        • 7.3.1 Endo Perphenazine Production Sites and Area Served
        • 7.3.2 Perphenazine Product Introduction, Application and Specification
        • 7.3.3 Endo Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Mylan
        • 7.4.1 Mylan Perphenazine Production Sites and Area Served
        • 7.4.2 Perphenazine Product Introduction, Application and Specification
        • 7.4.3 Mylan Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 ZHPHARMA
        • 7.5.1 ZHPHARMA Perphenazine Production Sites and Area Served
        • 7.5.2 Perphenazine Product Introduction, Application and Specification
        • 7.5.3 ZHPHARMA Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Shandong Boshan Pharma
        • 7.6.1 Shandong Boshan Pharma Perphenazine Production Sites and Area Served
        • 7.6.2 Perphenazine Product Introduction, Application and Specification
        • 7.6.3 Shandong Boshan Pharma Perphenazine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served

      8 Perphenazine Manufacturing Cost Analysis

      • 8.1 Perphenazine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Perphenazine
      • 8.4 Perphenazine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Perphenazine Distributors List
      • 9.3 Perphenazine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Perphenazine Market Forecast

      • 11.1 Global Perphenazine Production, Revenue Forecast
        • 11.1.1 Global Perphenazine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Perphenazine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Perphenazine Price and Trend Forecast (2019-2025)
      • 11.2 Global Perphenazine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Perphenazine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Perphenazine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Perphenazine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Perphenazine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Perphenazine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Perphenazine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Perphenazine Consumption Forecast (2019-2025)
        • 11.3.3 China Perphenazine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Perphenazine Consumption Forecast (2019-2025)
      • 11.4 Global Perphenazine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Perphenazine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
        The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

        The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.

        Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.

        North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.

        Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

        The global Perphenazine market is valued at 95 million US$ in 2018 is expected to reach 100 million US$ by the end of 2025, growing at a CAGR of 0.6% during 2019-2025.
        This report focuses on Perphenazine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Perphenazine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Teva
        Sandoz
        Endo
        Mylan
        ZHPHARMA
        Shandong Boshan Pharma
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oral Forms
        Injectable Solution

        Segment by Application
        Psychosis
        Antiemetic

        Buy now